|
[1]
|
Siegel, R., Miller, K., Goding Sauer, A., Fedewa, S., Butterly, L., Anderson, J., Cercek, A., Smith, R. and Jemal, A. (2020) Colorectal Cancer Statistics, 2020. CA: A Cancer Journal for Clinicians, 70, 145-164. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Janković, S. and Radosavljević, V. (2007) Risk Factors for Bladder Cancer. Tumori, 93, 4-12. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Nowak, S. and Corces, V. (2004) Phosphorylation of Histone H3: A Balancing Act between Chromosome Condensation and Transcriptional Activation. Trends in Genetics: TIG, 20, 214-220. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Zhu, P., Zhang, C., Yang, P., Chen, J., Liu, Y., Hu, H., Huang, H., Bao, Z., Zhang, W., Kong, W., et al. (2016) Phosphohistone H3 (pHH3) Is a Prognostic and Epithelial to Mesenchymal Transition Marker in Diffuse Gliomas. Oncotarget, 7, 45005-45014. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Ribalta, T., McCutcheon, I., Aldape, K., Bruner, J. and Fuller, G. (2004) The Mitosis-Specific Antibody Anti-Phosphohistone-H3 (PHH3) Facilitates Rapid Reliable Grading of Meningiomas According to WHO 2000 Criteria. The American Journal of Surgical Pathology, 28, 1532-1536. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Yang, R., Liao, Z., Cai, Y. and Kong, J. (2018) LASP2 Suppressed Malignancy and Wnt/β-Catenin Signaling Pathway Activation In Bladder Cancer. Experimental and Therapeutic Medicine, 16, 5215-5223. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Jacobs, B., Lee, C. and Montie, J. (2010) Bladder Cancer in 2010: How Far Have We Come? CA: A Cancer Journal for Clinicians, 60, 244-272. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Ladstein, R., Bachmann, I., Straume, O. and Akslen, L. (2010) Ki-67 Expression Is Superior to Mitotic Count and Novel Proliferation Markers PHH3, MCM4 and Mitosin as a Prognostic Factor in Thick Cutaneous Melanoma. BMC Cancer, 10, 140. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
韩换. PHH3和NKX6-1在胰腺神经内分泌肿瘤中的表达及其意义[D]: [硕士学位论文]. 上海: 第二军医大学, 2017.
|
|
[10]
|
Aune, G., Stunes, A., Tingulstad, S., Salvesen, O., Syversen, U. and Torp, S. (2011) The Proliferation Markers Ki-67/MIB-1, Phosphohistone H3, and Survivin May Contribute in the Identification of Aggressive Ovarian Carcinomas. International Journal of Clinical and Experimental Pathology, 4, 444-453.
|
|
[11]
|
Takahashi, H., Murai, Y., Tsuneyama, K., Nomoto, K., Okada, E., Fujita, H. and Takano, Y. (2006) Overexpression of Phosphorylated Histone H3 Is an Indicator of Poor Prognosis in Gastric Adenocarcinoma Patients. Applied Immunohistochemistry & Molecular Morphology: AIMM, 14, 296-302. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Hendzel, M., Wei, Y., Mancini, M., Van Hooser, A., Ranalli, T., Brinkley, B., Bazett-Jones, D. and Allis, C. (1997) Mitosis-Specific Phosphorylation of Histone H3 Initiates Primarily within Pericentromeric Heterochromatin during G2 and Spreads in an Ordered Fashion Coincident with Mitotic Chromosome Condensation. Chromosoma, 106, 348-360. [Google Scholar] [CrossRef] [PubMed]
|